FDA.reportPublic FDA data

Device Listing 1331410922

Listing Summary#

Listing key
1331410922
Premarket submission
K120051
Device
SODIUM CHLORIDE INHALATION SOLUTION, 3%, 7%, AND 10%, USP-4ML
Applicant
Nephron Pharmaceuticals Corp.
Product code
CAF
Decision date
2012-04-20